Photo of Sander Houten
Sander Houten, PhD
    • Position
    • ASSOCIATE PROFESSOR | Genetics and Genomic Sciences
    • Language
    • English

Dr. Sander M. Houten has a Ph.D. from the faculty of Medicine of the University of Amsterdam where he worked on inborn errors of metabolism and discovered that a deficiency of mevalonate kinase causes hyper-IgD syndrome. For his postdoctoral studies, he moved to the Institut de Génétique et de Biologie Moléculaire et Cellulaire in Strasbourg, France and worked on mechanisms underlying the control of metabolism in vivo in mouse models and defined a novel bile acid signaling pathway via a G-protein-coupled receptor that increases energy expenditure. He then returned to the Academic Medical Center of the University of Amsterdam to develop his own research line on the pathophysiology of inborn errors of mitochondrial fatty acid oxidation in the laboratory Genetic Metabolic Diseases. He is currently an associate professor at Mount Sinai and will continue his research on fatty acid oxidation defects with the aim to develop new therapeutic options. In collaboration with the Institute for Genomics and Multiscale Biology, he will try to identify molecular markers of disease severity in inborn errors such as fatty acid oxidation disorders with the ultimate aim to find new disease modifiers.

To view a complete list of Dr. Houten's publication click here

Research Topic

Genetics, Mitochondria

Multi-Disciplinary Training Area

Genetics and Genomic Sciences [GGS]

Education

MSc, University of Amsterdam

PhD, University of Amsterdam

Language

English